2015 Q4 Form 10-K Financial Statement

#000143774917004710 Filed on March 16, 2017

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2015 Q2
Revenue $33.87M $107.1M $104.6M
YoY Change -61.73% 14.6% 56.27%
Cost Of Revenue $4.400M $96.98M $96.90M
YoY Change -92.61% 61.73% 102.44%
Gross Profit $29.51M $8.675M $5.544M
YoY Change 2.12% -58.44% -15.72%
Gross Profit Margin 87.13% 8.1% 5.3%
Selling, General & Admin $1.800M $2.000M $1.700M
YoY Change 5.88% 0.0% 13.33%
% of Gross Profit 6.1% 23.05% 30.66%
Research & Development $600.0K $738.0K $670.0K
YoY Change -33.33% 1.37% -22.9%
% of Gross Profit 2.03% 8.51% 12.09%
Depreciation & Amortization $2.710M $2.610M $2.570M
YoY Change 19.91% 19.18% 18.43%
% of Gross Profit 9.18% 30.09% 46.36%
Operating Expenses $2.400M $2.742M $2.367M
YoY Change -7.69% 1.67% -1.66%
Operating Profit $27.11M $5.933M $3.177M
YoY Change 3.09% -67.36% -23.83%
Interest Expense $0.00 $42.00K $43.00K
YoY Change -100.0% 600.0% 514.29%
% of Operating Profit 0.0% 0.71% 1.35%
Other Income/Expense, Net $0.00 $977.0K $1.735M
YoY Change -100.0% -30.71% -60.97%
Pretax Income $27.00M $6.910M $4.912M
YoY Change -7.22% -64.72% -42.99%
Income Tax -$2.600M $2.060M $1.119M
% Of Pretax Income -9.63% 29.81% 22.78%
Net Earnings $29.65M $4.850M $3.793M
YoY Change -1.5% -57.65% -29.06%
Net Earnings / Revenue 87.53% 4.53% 3.63%
Basic Earnings Per Share $0.68 $0.11 $0.09
Diluted Earnings Per Share $0.68 $0.11 $0.09
COMMON SHARES
Basic Shares Outstanding 43.71M 43.46M 43.42M
Diluted Shares Outstanding 43.46M 43.43M

Balance Sheet

Concept 2015 Q4 2015 Q3 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $225.6M $245.7M $224.4M
YoY Change 10.02% 26.06% 24.76%
Cash & Equivalents $154.0M $176.5M $142.4M
Short-Term Investments $71.50M $69.15M $82.09M
Other Short-Term Assets $3.887M $3.683M $1.282M
YoY Change 140.09% -38.62% -52.52%
Inventory $64.96M $34.37M $55.99M
Prepaid Expenses $1.642M $391.0K $946.0K
Receivables $46.32M $19.77M $19.65M
Other Receivables $14.10M $9.300M $17.70M
Total Short-Term Assets $359.8M $315.1M $329.2M
YoY Change 8.56% 3.32% 13.75%
LONG-TERM ASSETS
Property, Plant & Equipment $124.3M $125.8M $126.7M
YoY Change -2.39% -2.06% -2.21%
Goodwill
YoY Change
Intangibles $1.408M $1.408M $1.408M
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.078M $2.962M $2.861M
YoY Change 16.06% 13.92% 10.04%
Total Long-Term Assets $129.3M $130.6M $131.5M
YoY Change -0.57% -0.28% -0.5%
TOTAL ASSETS
Total Short-Term Assets $359.8M $315.1M $329.2M
Total Long-Term Assets $129.3M $130.6M $131.5M
Total Assets $489.1M $445.8M $460.7M
YoY Change 5.99% 2.24% 9.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.44M $18.69M $30.21M
YoY Change 13.35% -36.22% 60.7%
Accrued Expenses $2.976M $6.871M $6.682M
YoY Change -36.61% 5.71% -13.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $48.55M $32.85M $46.32M
YoY Change -6.78% -35.21% 4.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.219M $1.613M $3.362M
YoY Change -69.71% -91.28% -80.45%
Total Long-Term Liabilities $46.24M $47.24M $49.69M
YoY Change -8.23% 155.33% 188.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.55M $32.85M $46.32M
Total Long-Term Liabilities $46.24M $47.24M $49.69M
Total Liabilities $94.80M $80.08M $96.01M
YoY Change -7.5% -18.37% 6.91%
SHAREHOLDERS EQUITY
Retained Earnings $113.0M $86.00M $83.77M
YoY Change 46.6%
Common Stock $4.000K $4.000K $4.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $394.3M $365.7M $364.7M
YoY Change
Total Liabilities & Shareholders Equity $489.1M $445.8M $460.7M
YoY Change 5.99% 2.24% 9.28%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2015 Q2
OPERATING ACTIVITIES
Net Income $29.65M $4.850M $3.793M
YoY Change -1.5% -57.65% -29.06%
Depreciation, Depletion And Amortization $2.710M $2.610M $2.570M
YoY Change 19.91% 19.18% 18.43%
Cash From Operating Activities -$20.30M $25.06M -$6.240M
YoY Change -179.73% 5.96% -78.2%
INVESTING ACTIVITIES
Capital Expenditures -$1.190M -$1.670M -$1.820M
YoY Change -16.78% 72.16% -40.13%
Acquisitions
YoY Change
Other Investing Activities $1.590M $13.89M -$6.680M
YoY Change -90.46% -205.31% -133.27%
Cash From Investing Activities $400.0K $12.22M -$8.500M
YoY Change -97.37% -186.24% -149.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.600M -3.090M -3.340M
YoY Change -50.38% -42.78% -35.65%
NET CHANGE
Cash From Operating Activities -20.30M 25.06M -6.240M
Cash From Investing Activities 400.0K 12.22M -8.500M
Cash From Financing Activities -2.600M -3.090M -3.340M
Net Change In Cash -22.50M 34.19M -18.08M
YoY Change -163.47% 737.99% 7.94%
FREE CASH FLOW
Cash From Operating Activities -$20.30M $25.06M -$6.240M
Capital Expenditures -$1.190M -$1.670M -$1.820M
Free Cash Flow -$19.11M $26.73M -$4.420M
YoY Change -171.07% 8.57% -82.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016Q2 dei Entity Public Float
EntityPublicFloat
283248378
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016Q4 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
142000
CY2015Q4 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
CY2016Q4 ff Accrued Expenses And Other Currentliabilities
AccruedExpensesAndOtherCurrentliabilities
2485000
CY2015Q4 ff Accrued Expenses And Other Currentliabilities
AccruedExpensesAndOtherCurrentliabilities
2976000
CY2011Q1 ff Aggregate Amount Of Common And Preferred Stock Warrants Rights And Units Registered For Future Issuance
AggregateAmountOfCommonAndPreferredStockWarrantsRightsAndUnitsRegisteredForFutureIssuance
50000000
CY2013Q1 ff At The Market Offering Aggregate Shares Issued
AtTheMarketOfferingAggregateSharesIssued
3000000
CY2011Q2 ff At The Market Offering Maximum Shares Of Common Stock The Company May Sell
AtTheMarketOfferingMaximumSharesOfCommonStockTheCompanyMaySell
3000000
CY2011Q2 ff At The Market Offering Of Common Stock Term
AtTheMarketOfferingOfCommonStockTerm
P3Y
CY2016Q4 ff Blending Tax Credit
BlendingTaxCredit
5495000
CY2015Q4 ff Blending Tax Credit
BlendingTaxCredit
30895000
CY2016 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
-3621000
CY2015 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
3295000
CY2014 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
396000
CY2016 ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
10319000
CY2015 ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
6662000
CY2014 ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
58822000
CY2016Q4 ff Deferred Tax Liabilities Accrued Expenses
DeferredTaxLiabilitiesAccruedExpenses
CY2015Q4 ff Deferred Tax Liabilities Accrued Expenses
DeferredTaxLiabilitiesAccruedExpenses
656000
CY2016 ff Distribution Related Parties
DistributionRelatedParties
378000
CY2015 ff Distribution Related Parties
DistributionRelatedParties
405000
CY2014 ff Distribution Related Parties
DistributionRelatedParties
335000
CY2016 ff Excess Tax Benefit Expense From Sharebased Compensation Financing Activities
ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities
-137000
CY2015 ff Excess Tax Benefit Expense From Sharebased Compensation Financing Activities
ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities
-344000
CY2014 ff Excess Tax Benefit Expense From Sharebased Compensation Financing Activities
ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities
59000
CY2016 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
142000
CY2015 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
-46000
CY2014 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
43000
CY2016 ff Increase Decrease Prepaid Expenses Related Parties
IncreaseDecreasePrepaidExpensesRelatedParties
-23000
CY2015 ff Increase Decrease Prepaid Expenses Related Parties
IncreaseDecreasePrepaidExpensesRelatedParties
35000
CY2014 ff Increase Decrease Prepaid Expenses Related Parties
IncreaseDecreasePrepaidExpensesRelatedParties
CY2013Q1 ff Net Proceeds From Issuance Of Common Stock After Commissions And Fees
NetProceedsFromIssuanceOfCommonStockAfterCommissionsAndFees
36127000
CY2006Q3 ff Number Of Shares Of Common Stock Subject To Registration Rights Agreement
NumberOfSharesOfCommonStockSubjectToRegistrationRightsAgreement
16250000
CY2016Q4 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
12000
CY2015Q4 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
35000
CY2016 ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
244822000
CY2015 ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
234630000
CY2014 ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
302748000
CY2016 ff Share Based Compensation Arrangement By Share Based Payment Award Award Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTerm
P10Y
CY2016 ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
-264000
CY2015 ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
237000
CY2014 ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
258000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22799000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34442000
CY2016Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1254000
CY2015Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
244000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24359000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46319000
CY2016Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
385000
CY2015Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
10000
CY2016Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1428000
CY2015Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1248000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2627000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2976000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
79432000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
68764000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3540000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2055000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4259000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281087000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
279231000
CY2014 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
59000
CY2015 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-344000
CY2016 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-137000
CY2014 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
175000
CY2015 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
120000
CY2016 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
128000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1440000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2043000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1908000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1908000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2043000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1440000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
144000
CY2015 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
65000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
97500
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25000
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
178000
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
CY2014 us-gaap Asset Impairment Charges
AssetImpairmentCharges
247000
CY2016Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
849000
CY2015Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
822000
CY2014Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
796000
CY2016 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
27000
CY2015 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
26000
CY2016Q4 us-gaap Assets
Assets
529043000
CY2015Q4 us-gaap Assets
Assets
489109000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
405282000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
359824000
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
123761000
CY2015Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
129285000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
728
CY2015 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
2402000
CY2014 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
5712000
CY2016 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
-1340000
CY2015 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
107000
CY2016Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
26171000
CY2015Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
26478000
CY2016 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
471000
CY2015 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2014 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199272000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154049000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124079000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86463000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
45223000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
29970000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
37616000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43749970
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43715832
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43749970
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43715832
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
57826000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44217000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50023000
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Customer concentrations</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Significant portions of FutureFuel<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s sales are made to a relatively small number of customers. All sales of a laundry detergent additive were made to a leading North American consumer products company. Sales of the laundry detergent additive were less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total revenue for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> </div>Such sales were<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$43,927.</div> Sales to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> biodiesel customer totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$35,568,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$33,255,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$62,994</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> respectively.&nbsp; Additionally, sales of biodiesel, petrodiesel, petrodiesel blends, and other petroleum products to a related party totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$64,981</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$39,090</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> respectively. For the period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> sales to the related party were not greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%.</div>&nbsp;See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19</div> below.</div></div></div></div>
CY2016Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2271000
CY2015Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3586000
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
191662000
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
233063000
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
213172000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-13014000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7475000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8455000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1120000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
487000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1306000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1437000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2283000
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3858000
CY2016Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
144000
CY2015Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
144000
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
325000
CY2015Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
469000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5271000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3721000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5388000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
45703000
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
48217000
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
22322000
CY2015Q4 us-gaap Deferred Revenue
DeferredRevenue
18588000
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
17867000
CY2016 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
7752000
CY2015 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
3365000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5530000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2680000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
16792000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
15908000
CY2016 us-gaap Deferred Revenue Refund Payments1
DeferredRevenueRefundPayments1
CY2015 us-gaap Deferred Revenue Refund Payments1
DeferredRevenueRefundPayments1
176000
CY2016 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
4018000
CY2015 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2468000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
36000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-231000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
526000
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
9388000
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
9993000
CY2016Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
90000
CY2015Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13639000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12040000
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1149000
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1244000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2546000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
249000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
77000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
144000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations
299000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations
299000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
90000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
111000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
32064000
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
36177000
CY2016Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
CY2015Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
7060000
CY2016Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
5821000
CY2015Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
5163000
CY2016Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
CY2015Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
1348000
CY2016Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
1376000
CY2015Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
1075000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
32064000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
29117000
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
213000
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
45000
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
38293000
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
39930000
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1540000
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1648000
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1683000
CY2016 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2015 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2014 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2016 us-gaap Depreciation
Depreciation
10819000
CY2015 us-gaap Depreciation
Depreciation
10187000
CY2014 us-gaap Depreciation
Depreciation
8891000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10819000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10187000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8981000
CY2016Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-258000
CY2015Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
3362000
CY2016 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-6220000
CY2015 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
9101000
CY2014 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
12757000
CY2016 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr> <td style="width: 6.4%; vertical-align: top;"><div style=" margin: 0pt 1.6pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25)</div></div> </td> <td style="width: 93.6%; vertical-align: top;"> <div style=" margin: 0pt 1.6pt 0pt -18pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Recently issued accounting standards</div> </td> </tr> </table> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the FASB and International Accounting Standards Board jointly issued new principles-based accounting guidance for revenue recognition that will supersede virtually all existing revenue guidance. The core principle of this guidance is that an <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. To achieve the core principle, the guidance establishes the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps: <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1)</div> identify the contract(s) with a customer, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2)</div> identify the performance obligation in the contract, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3)</div> determine the transaction price, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4)</div> allocate the transaction price to the performance obligations in the contract, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5)</div> recognize revenue when (or as) the entity satisfies a performance obligation. The guidance also details the accounting treatment for costs to obtain or fulfill a contract. Lastly, disclosure requirements have been enhanced to provide sufficient information to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. This guidance is effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> including interim periods within that reporting period. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB affirmed its proposal to defer the effective date by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued improvements and practical expedients to the standard that included clarification of the collectability criterion, noncash considerations as well as clarification of options at transition. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued additional corrections and improvements. The Company is in the process of evaluating the impact of this guidance.&nbsp;This new guidance,&nbsp;will likely&nbsp;result in a change in the nature and extent of the related footnote disclosures. The Company plans to adopt the new guidance when effective and presently anticipates adopting on a modified retrospective basis to each prior reporting period presented with the election of applicable practical expedients. </div></div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued guidance to reduce existing diversity in practice in regards to how cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance specifically addresses the following items: debt</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">prepayment or debt extinguishment costs; settlement of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero</div>-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies; distributions received from equity method investees; beneficial interest in securitization transactions; and separately identifiable cash flows and application of the predominance principle. This guidance is effective for annual reporting periods beginning after&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within that reporting period and early adoption is permitted, including adoption in an interim period. The new guidance is to be applied retrospectively to each period presented at the date of adoption. FutureFuel has concluded this guidance will have a minimal impact on the Company&#x2019;s statement of cash flows and related disclosures and plans to adopt in accordance with the guidance.</div></div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued new guidance related to credit losses. The new guidance replaces the incurred loss impairment methodology in current GAAP with an expected cre<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">dit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. Purchased credit deteriorated loans will receive an allowance account for expected credit losses at the acquisition date that represents a component of the purchase price allocation. Credit losses relating to available for sale debt securities will be recorded through an allowance for expected credit losses, with such allowance limited to the amount by which fair value is below amortized cost. An allowance will be established for estimated credit losses on held to maturity securities. This guidance is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and interim periods within those fiscal years. FutureFuel has historically had minor credit losses and therefore expects this standard to have minimal to no impact on the Company&#x2019;s financial position and results of operations and related disclosures.</div></div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued guidance in regards to stock compensat<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">ion as a part of the simplification initiative that covers related tax accounting, cash flow presentation, and forfeitures. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> tax accounting related amendments are as follows: all excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) should be recognized as income tax expense or benefit in the income statement, the tax effects of exercised or vested awards should be treated as discrete items in the reporting period in which they occur, an entity also should recognize excess tax benefits regardless of whether the benefit reduces taxes payable in the current period; and the threshold to qualify for equity classification permits withholding up to the maximum statutory tax rates in the applicable jurisdictions. The cash flow presentation items set forth that excess tax benefits should be classified along with other income tax cash flows as an operating activity and cash paid by an employer when directly withholding shares for tax withholding purposes should be classified as a financing activity. For forfeitures, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest (current GAAP) or account for forfeitures when they occur. This guidance is effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> including interim periods within that reporting period and early adoption is permitted, including adoption in an interim period. Management has determined this standard will not have a material impact on the Company's financial position and results of operations and related disclosures.</div></div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> a pronouncement was issued that creates new accounting and reporting guidelines for leasing arrangements. The new guidance <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">requires organizations that lease assets to recognize assets and liabilities on the balance sheet related to the rights and obligations created by those leases, regardless of whether they are classified as finance or operating leases. Consistent with current guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease primarily will depend on its classification as a finance or operating lease. The guidance also requires new disclosures in order to help users of financial statements better understand the amount, timing, and uncertainty of cash flows arising from leases. The new standard is effective for annual reporting periods beginning after&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> including interim periods within that reporting period, with early application permitted. The new standard is to be applied using a modified retrospective approach. FutureFuel is currently evaluating the impact of the new pronouncement on its financial statements.</div></div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued guidance <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">under the simplification and productivity initiative for presentation of deferred income tax liabilities and assets. This guidance simplifies the presentation of deferred income taxes such that deferred tax liabilities and assets are to be classified as noncurrent in a classified balance sheet. The update does not amend the current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount. This guidance was effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> with early adoption permitted. The Company elected to adopt this standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> on a prospective basis. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> financial statements were not retrospectively adjusted. The adoption of this guidance resulted in a decrease in current deferred income tax liability by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,188</div> and an increase in noncurrent deferred income tax liability of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,188.</div></div></div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Financial Accounting Standards Board issued new guidance that requires <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">inventory not measured using either the last in, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> out (LIFO) or the retail inventory method to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable cost of completion, disposal, and transportation. The new standard will be effective for periods on or after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and will be applied prospectively. FutureFuel has concluded that the change in accounting required by this standard will not materially impact the Company&#x2019;s financial position or results of operations and related disclosures.</div></div></div>
CY2016 us-gaap Distributed Earnings
DistributedEarnings
377000
CY2015 us-gaap Distributed Earnings
DistributedEarnings
66000
CY2014 us-gaap Distributed Earnings
DistributedEarnings
114000
CY2014 us-gaap Dividends
Dividends
20928000
CY2015 us-gaap Dividends
Dividends
10493000
CY2016 us-gaap Dividends
Dividends
121181000
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
110688000
CY2015Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
CY2016Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
110688000
CY2015Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2014Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.22
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.29
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
864000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1474000
CY2016 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
213000
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P335D
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
75000
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
23000
CY2016 us-gaap Gain Loss On Investments
GainLossOnInvestments
843000
CY2015 us-gaap Gain Loss On Investments
GainLossOnInvestments
713000
CY2014 us-gaap Gain Loss On Investments
GainLossOnInvestments
4335000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-147000
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-178000
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-108000
CY2016 us-gaap Gross Profit
GrossProfit
46858000
CY2015 us-gaap Gross Profit
GrossProfit
57046000
CY2014 us-gaap Gross Profit
GrossProfit
65973000
CY2016Q1 us-gaap Gross Profit
GrossProfit
11053000
CY2016Q2 us-gaap Gross Profit
GrossProfit
7972000
CY2016Q3 us-gaap Gross Profit
GrossProfit
10319000
CY2016Q4 us-gaap Gross Profit
GrossProfit
17514000
CY2015Q1 us-gaap Gross Profit
GrossProfit
13314000
CY2015Q2 us-gaap Gross Profit
GrossProfit
5544000
CY2015Q3 us-gaap Gross Profit
GrossProfit
8675000
CY2015Q4 us-gaap Gross Profit
GrossProfit
29513000
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2015 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2016 us-gaap Impairment Of Investments
ImpairmentOfInvestments
2184000
CY2015 us-gaap Impairment Of Investments
ImpairmentOfInvestments
606000
CY2014 us-gaap Impairment Of Investments
ImpairmentOfInvestments
CY2015 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-792000
CY2014 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-2409000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40806000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
51869000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
67345000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15535000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5448000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14145000
CY2016 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
730000
CY2015 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
427000
CY2014 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
336000
CY2016 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
CY2015 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
163000
CY2014 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
14282000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
18154000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
23571000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
193000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-747000
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
1309000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-94000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-288000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
222000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1262000
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
695000
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3189000
CY2016 us-gaap Income Tax Reconciliation Tax Contingencies Domestic
IncomeTaxReconciliationTaxContingenciesDomestic
-20048000
CY2015 us-gaap Income Tax Reconciliation Tax Contingencies Domestic
IncomeTaxReconciliationTaxContingenciesDomestic
-9958000
CY2014 us-gaap Income Tax Reconciliation Tax Contingencies Domestic
IncomeTaxReconciliationTaxContingenciesDomestic
-10344000
CY2016 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-6845000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
CY2015 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
CY2014 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
2000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
975000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
975000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
975000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
56000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
51000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
80000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
987000
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
13381000
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
12372000
CY2016Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
20508000
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
14114000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11643000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4056000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15459000
CY2016 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1010000
CY2015 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-2668000
CY2014 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
2055000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21960000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3816000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21515000
CY2016 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
375000
CY2015 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1163000
CY2014 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-3456000
CY2016 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
110000
CY2015 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-30000
CY2014 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-99000
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-645000
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1673000
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3153000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3734000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
721000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2524000
CY2016 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
6394000
CY2015 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5602000
CY2014 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4984000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12864000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19604000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3189000
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1762000
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2831000
CY2014 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1309000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
556000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
668000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-65000
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
52000
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-28000
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-173000
CY2016 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
535000
CY2015 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-1239000
CY2014 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
985000
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4753
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13581
CY2014 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
34409
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1408000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1408000
CY2016 us-gaap Interest Expense
InterestExpense
173000
CY2015 us-gaap Interest Expense
InterestExpense
134000
CY2014 us-gaap Interest Expense
InterestExpense
25000
CY2016 us-gaap Interest Expense Other
InterestExpenseOther
27000
CY2015 us-gaap Interest Expense Other
InterestExpenseOther
26000
CY2014 us-gaap Interest Expense Other
InterestExpenseOther
25000
CY2016 us-gaap Interest Paid
InterestPaid
CY2015 us-gaap Interest Paid
InterestPaid
CY2014 us-gaap Interest Paid
InterestPaid
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27971000
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35517000
CY2016Q4 us-gaap Inventory Gross
InventoryGross
55011000
CY2015Q4 us-gaap Inventory Gross
InventoryGross
68459000
CY2016Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2918000
CY2015Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
3502000
CY2016 us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
1435000
CY2015 us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
1595000
CY2016Q4 us-gaap Inventory Net
InventoryNet
52093000
CY2015Q4 us-gaap Inventory Net
InventoryNet
64957000
CY2016Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
25127000
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
31247000
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1913000
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1695000
CY2016 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
6152000
CY2015 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
5106000
CY2014 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
6877000
CY2016 us-gaap Investment Income Net
InvestmentIncomeNet
6152000
CY2015 us-gaap Investment Income Net
InvestmentIncomeNet
5213000
CY2014 us-gaap Investment Income Net
InvestmentIncomeNet
6877000
CY2016Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
31126000
CY2015Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
15571000
CY2016 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4921000
CY2015 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4955000
CY2014 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4268000
CY2016Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
5741000
CY2015Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
5741000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1121000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1060000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
946000
CY2016Q4 us-gaap Liabilities
Liabilities
196230000
CY2015Q4 us-gaap Liabilities
Liabilities
94797000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
529043000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
489109000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
144049000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
48553000
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
52181000
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
46244000
CY2016Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
1151000
CY2015Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
1151000
CY2016Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
163401000
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
157289000
CY2016Q4 us-gaap Marketable Securities
MarketableSecurities
100339000
CY2015Q4 us-gaap Marketable Securities
MarketableSecurities
71503000
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
106146000
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
74667000
CY2016 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-1340000
CY2015 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
107000
CY2014 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
4335000
CY2016 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr> <td style="width: 6.4%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1)</div></div> </td> <td style="width: 93.6%; vertical-align: top;"> <div style=" margin: 0pt 0.8pt 0pt -18pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Nature of operations and basis of presentation</div> </td> </tr> </table> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Viceroy Acquisition Corporation</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Viceroy Acquisition Corporation (&#x201c;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">Viceroy&#x201d;) was incorporated under the laws of the state of Delaware on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> to serve as a vehicle for the acquisition of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> or more operating businesses in the oil and gas industry. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2006,</div> Viceroy completed an equity offering (see Note&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16).</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2006,</div> Viceroy acquired all of the issued and outstanding shares of Eastman SE, Inc. (&#x201c;Eastman SE&#x201d;) from Eastman Chemical Company (&#x201c;Eastman Chemical&#x201d;). Immediately subsequent to the acquisition, Viceroy changed its name to FutureFuel Corp. (&#x201c;FutureFuel&#x201d;) and Eastman SE changed its name to FutureFuel Chemical Company (&#x201c;FutureFuel Chemical&#x201d;).</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Eastman SE, Inc.</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Eastman SE was incorporated under the laws of the state of Delaware on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> and subsequent thereto operated as a wholly owned subsidiary of Eastman Chemical through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2006.</div> Eastman SE was incorporated for purposes of effecting a sale of Eastman Chemical&#x2019;s manufacturing facility in Batesville, Arkansas (the &#x201c;Batesville Plant&#x201d;).</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Batesville Plant was constructed to produce pro<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">prietary photographic chemicals for Eastman Kodak Company (&#x201c;Eastman Kodak&#x201d;). Over the years, Eastman Kodak shifted the plant&#x2019;s focus away from the photographic imaging business to the custom synthesis of fine chemicals and organic chemical intermediates used in a variety of end markets, including paints and coatings, plastics and polymers, pharmaceuticals, food supplements, household detergents, and agricultural products.</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005,</div> the Batesville Plant began the implementation of a bio-based products platf<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">orm. This included the production of biofuels (biodiesel) and bio-based specialty chemical products (bio-based solvents, chemicals, and intermediates). In addition to bio-based products, the Batesville Plant continues to manufacture specialty and other organic chemicals.</div></div></div>
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10545000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11678000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21044000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35207000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2025000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6708000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
90975000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39623000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51952000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
18680000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
56341000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
46421000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
53200000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
10569000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
14224000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
12868000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
8131000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
3793000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
4850000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
29647000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4283000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4898000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11217000
CY2016 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2016 us-gaap Operating Expenses
OperatingExpenses
10335000
CY2015 us-gaap Operating Expenses
OperatingExpenses
10075000
CY2014 us-gaap Operating Expenses
OperatingExpenses
9845000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
36523000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
46971000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
56128000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1346000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
714000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
95000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
95000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
95000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
132000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
215000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
335000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
254000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
669000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3887000
CY2016Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
106146000
CY2015Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
74667000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3876000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3078000
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-1340000
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
107000
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-870000
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
70000
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-470000
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
37000
CY2016 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
615000
CY2015 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-2134000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3177000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2204000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1485000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1485000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2204000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3177000
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
1419000
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
394000
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
765000
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
212000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
2643000
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-3518000
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-5157000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1485000
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2204000
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3177000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1158000
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1314000
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1980000
CY2016 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2176000
CY2015 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2164000
CY2014 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2195000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3325000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1219000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-356000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-181000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000
CY2016 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1869000
CY2015 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-315000
CY2014 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
4340000
CY2016 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
56228000
CY2015 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
46118000
CY2014 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
52828000
CY2016 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
56228000
CY2015 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
46118000
CY2014 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
52828000
CY2016 us-gaap Payments Of Dividends
PaymentsOfDividends
10493000
CY2015 us-gaap Payments Of Dividends
PaymentsOfDividends
10493000
CY2014 us-gaap Payments Of Dividends
PaymentsOfDividends
20928000
CY2016 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
CY2015 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
721000
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
128000
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
120000
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
175000
CY2015Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1408000
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1408000
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2016 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
60664000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7222000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8117000
CY2015 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
39136000
CY2014 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
41369000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4495000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1694000
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1642000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
213000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30487000
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
48546000
CY2014 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
57098000
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
81000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
118152000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124330000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
225000
CY2016 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-870000
CY2015 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
70000
CY2016 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
523000
CY2015 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
215000
CY2014 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
214000
CY2016 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
523000
CY2015 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
215000
CY2014 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
214000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2715000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2741000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3168000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
758000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48182000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
113022000
CY2016 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
8371000
CY2015 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
64981000
CY2014 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
39090000
CY2016 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Deferred revenue</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">FutureFuel has signed contracts with c<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">ustomers to construct plant and related assets on FutureFuel&#x2019;s property for the manufacture of custom chemicals. The cost of construction has been funded by the customers with title and risk of loss to the equipment residing with FutureFuel. Reimbursements are recognized as deferred revenue and are amortized over the expected life of the customer relationship starting upon the completion of construction and the asset being placed into service.</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Additionally, FutureFuel has been awarded grants from governme<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">ntal agencies related to the construction of production equipment and infrastructural improvements at its plant site. The cost of construction of these projects has been either funded by the governmental agencies directly or funded by FutureFuel who has then been reimbursed by the governmental agencies. Direct payments and reimbursements for construction costs have been recognized as deferred revenue and will be amortized into earnings over the expected life of the applicable customer relationship or the life of the asset if no direct customer relationship is tied to the asset. Such amortization will not begin until the asset has been placed into service and all contingencies associated with the grants are fulfilled.</div></div></div></div>
CY2016Q1 us-gaap Revenues
Revenues
46635000
CY2016Q2 us-gaap Revenues
Revenues
67879000
CY2016Q3 us-gaap Revenues
Revenues
69306000
CY2016Q4 us-gaap Revenues
Revenues
69373000
CY2015Q1 us-gaap Revenues
Revenues
54087000
CY2015Q2 us-gaap Revenues
Revenues
104598000
CY2015Q3 us-gaap Revenues
Revenues
107054000
CY2015Q4 us-gaap Revenues
Revenues
33872000
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
253193000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
299611000
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
341838000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.55
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.78
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
70000
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.45
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.34
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.99
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1908000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2043000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1440000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1194700
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
60000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.74
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
90000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
102000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
378000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
180611
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
240000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
250000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.70
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.77
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.05
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.48
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.1
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.06
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.68
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
13.33
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3.37
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
26000
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
248000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
90000
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
60000
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
30000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.78
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.78
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.78
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y335D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y335D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P335D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y259D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
60000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
30000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.67
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.78
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
40000
CY2016 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P12Y175D
CY2016 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
3976000
CY2015 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
2435000
CY2014 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
3536000
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30611
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
120000
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37247000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
213000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
332813000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
394312000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
328590000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
359009000
CY2016 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-264000
CY2015 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
237000
CY2014 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
258000
CY2016 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-264000
CY2015 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
237000
CY2014 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
258000
CY2016 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
6844000
CY2015 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
4063000
CY2016 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
1037000
CY2015 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
899000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2056000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4588000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2981000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1718000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
4588000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
2981000
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
193000
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
61000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2056000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1471000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1255000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
3117000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
8000
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Use of estimates</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 36pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with accounting <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during a reporting period. Estimates are used when accounting for allowance for doubtful accounts, depreciation, amortization, asset retirement obligations, and income taxes as well as the evaluation of potential losses due to impairments or future liabilities. Actual results could differ materially from those estimates.</div></div></div></div>
CY2015Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
5035000
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4481000
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
9924000
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
10640000
CY2016 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
341000
CY2015 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
75000
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43357602
CY2014 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
229000
CY2016 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
895000
CY2015 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
4964000
CY2014 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
945000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43547538
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43445730
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43392011
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43542785
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43432149

Files In Submission

Name View Source Status
0001437749-17-004710-index-headers.html Edgar Link pending
0001437749-17-004710-index.html Edgar Link pending
0001437749-17-004710.txt Edgar Link pending
0001437749-17-004710-xbrl.zip Edgar Link pending
ex11.htm Edgar Link pending
ex21.htm Edgar Link pending
ex23.htm Edgar Link pending
ex31-a.htm Edgar Link pending
ex31-b.htm Edgar Link pending
ex32.htm Edgar Link pending
ff-20161231.xml Edgar Link completed
ff-20161231.xsd Edgar Link pending
ff-20161231_cal.xml Edgar Link unprocessable
ff-20161231_def.xml Edgar Link unprocessable
ff-20161231_lab.xml Edgar Link unprocessable
ff-20161231_pre.xml Edgar Link unprocessable
ff20161129_10k.htm Edgar Link pending
ff20161129_10kimg004.gif Edgar Link pending
ff20161129_10kimg005.gif Edgar Link pending
ff20161129_10kimg006.gif Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending